36.6 F
New York
Thursday, April 22, 2021

BioNTech [NASDAQ: BNTX] Expects To File For Regulatory Approval By The End Of 2020

Must read

Palantir [NYSE: PLTR] Recognized as a Crown Commercial Service supplier

Palantir Technologies Inc. has gained recognition as a supplier on the Crown Commercial Service (CCS) Back Office Software (BOS) RM6194 Framework. This award...

Trevena [NASDAQ: TRVN] Soar on Selection of TRV027in Global COVID-19 Trial

Shares of Trevena, Inc. skyrocketed more than 5 percent during the pre-market trading session of Wednesday. The strong performance of the firm indicated...

InfuSystem Announces Acquisition of OB Healthcare Corporation

InfuSystem Holdings Inc. disclosed Wednesday that it has bought OB Healthcare Corporation. As per the acquisition agreement, the firm has purchased the operating...

IAA [NYSE: IAA] Announces Expansion of Delivery Services in the UK

IAA, Inc. disclosed that its UK-based business unit has decided to expand its vehicle delivery services for its buyers. This expansion decision has...

BioNTech SE [NASDAQ: BNTX] disclosed Thursday that it is confident to begin the mass production of vaccine before acquiring the regulatory approval. CEO of BioNtech said that it will be ready to get regulatory approval by the end of the year.

BioNtech CEO and co-founder Dr. Ugur Sahin disclosed that the firm will produce over 1 billion doses by the end of 2021. It has partnered with Pfizer Inc. [NYSE: PFE]. He told the Wall Street Journal that several hundred million doses could be produced even before regulatory approval.

Pfizer and Biotech’s development program consist four vaccine candidates, each representing a different blend of mRNA format and target antigen. The new design of the trial allows for simultaneous review of multiple mRNA candidates in order to identify the safest and possibly most effective candidate for screening as many volunteers as possible. It will be easier to exchange data with regulatory authorities in real time.

Shares of BioNTech SE traded down 2.89% at $65.61 during the last trading session of Thursday. It has a day low and day high range of $64.51-$68.00, respectively. This company’s trading volume is 1.19 million as compared to the average volume of 1.83 million.

From the past 52-weeks of trading, it had fluctuted from the low of $12.52 and a peak of $105.00. Continuing to look at its profitabilty, its gross margin is 88.30% and return on investment is -31.40%.

On the other hand, Pfizer Inc. [NYSE: PFE] shares soared 0.63% at $33.67 during the trading of Friday. Its gross margin is 80.40%, the profit margin is 31.20%, and an operating margin is 32.10%. Its return on assets is 9.60%, return on investment is 14.70%, and return on equity is 25.00%.

More articles

Latest article

ICON [NASDAQ: ICLR] Secures Multiple Categories in 2021 CRO Leadership Awards

ICON Public Limited Company has disclosed that it has won multiple categories in the annual CRO Leadership Awards. This is another greatest achievement...

Equinox Announces Sale of Pilar Gold Mine

Equinox Gold Corp. revealed Monday that it has decided to sell its Pilar Gold Mine in Brazil to Pilar Gold Inc. The firm...

OpGen [NASDAQ: OPGN] Announces Strategic Collaboration New York State Department of Health

OpGen, Inc. revealed that it has entered into a strategic collaboration deal with the New York State Department of Health. The focus of...

Why Mer Telemanagement [NASDAQ: MTSL] Skyrocketed on Friday?

Shares of Mer Telemanagement Solutions Ltd skyrocketed during the trading session of Friday. The strong performance of the firm has indicated the positive...

Largo Resources Gets Approval for Listing on Nasdaq Stock Exchange

Largo Resources disclosed that it has finally obtained authorization from Nasdaq Stock Market LLC. As per the approval, the firm will now eligible to...

Aurora Mobile [NASDAQ: JG] Inks Agreement with Wanda Film

Aurora Mobile Limited disclosed Thursday that it has inked an agreement with Wanda Film Holding Co Ltd. Since its inception, Aurora Mobile has...

Brady [NYSE: BRC] Commence Tender Offer to Buy Nordic ID Oyj

Brady Corporation has inked an agreement with Nordic ID for its acquisition. The firm has commenced the tender offering to buy all the...

Cinedigm [NASDAQ: CIDM] Achieve Record Subscription and Ad-Supported User Growth Milestones

Shares of Cinedigm Corp. skyrocketed 19.30% after the firm reported the update about the subscription. The firm has achieved the best ever achievement...